Cholesterol Regulation in Familial Hypercholesterolemia by Long Noncoding RNA
Abstract
Familial Hypercholesterolemia (FH) is a genetic disorder within the FY21 PRMRP Topic Areas. Whether long non-coding RNAs (lncRNAs) have the therapeutic potential in FH remains unclear. In our preliminary study, we identified a lncRNA as a regulator of cholesterol metabolism and a potential therapeutic target for FH. During the research period, we have further confirm edits critical role in cholesterol metabolism in hepatocytes. Moreover, we have found that this lncRNA regulates cholesterol metabolism through the transcription factor SREBP2. To study the function of this lncRNA in vivo, we have produced adenovirus vector for overexpression of this lncRNA. We found that overexpressing this lncRNA in mouse liver suppresses the expression of SREBP2 pathway genes. Consistent with this, the liver and blood cholesterol levels were decreased. We also found that the overexpression of this lncRNA suppresses the transcription of the SREBP2 pathway genes by performing CHIP-PCR analysis.
Document Details
- Document Type
- Technical Report
- Publication Date
- Mar 01, 2023
- Accession Number
- AD1202720
Entities
People
- Ling Yang
Organizations
- Temple University